These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 22805180)
1. Prolonged tenofovir treatment of macaques infected with K65R reverse transcriptase mutants of SIV results in the development of antiviral immune responses that control virus replication after drug withdrawal. Van Rompay KK; Trott KA; Jayashankar K; Geng Y; LaBranche CC; Johnson JA; Landucci G; Lipscomb J; Tarara RP; Canfield DR; Heneine W; Forthal DN; Montefiori D; Abel K Retrovirology; 2012 Jul; 9():57. PubMed ID: 22805180 [TBL] [Abstract][Full Text] [Related]
2. Sequential emergence and clinical implications of viral mutants with K70E and K65R mutation in reverse transcriptase during prolonged tenofovir monotherapy in rhesus macaques with chronic RT-SHIV infection. Van Rompay KK; Johnson JA; Blackwood EJ; Singh RP; Lipscomb J; Matthews TB; Marthas ML; Pedersen NC; Bischofberger N; Heneine W; North TW Retrovirology; 2007 Apr; 4():25. PubMed ID: 17417971 [TBL] [Abstract][Full Text] [Related]
8. The clinical benefits of tenofovir for simian immunodeficiency virus-infected macaques are larger than predicted by its effects on standard viral and immunologic parameters. Van Rompay KK; Singh RP; Brignolo LL; Lawson JR; Schmidt KA; Pahar B; Canfield DR; Tarara RP; Sodora DL; Bischofberger N; Marthas ML J Acquir Immune Defic Syndr; 2004 Aug; 36(4):900-14. PubMed ID: 15220696 [TBL] [Abstract][Full Text] [Related]
9. Antiretroviral therapy during primary immunodeficiency virus infection can induce persistent suppression of virus load and protection from heterologous challenge in rhesus macaques. Rosenwirth B; ten Haaft P; Bogers WM; Nieuwenhuis IG; Niphuis H; Kuhn EM; Bischofberger N; Heeney JL; Uberla K J Virol; 2000 Feb; 74(4):1704-11. PubMed ID: 10644340 [TBL] [Abstract][Full Text] [Related]
10. Adoptive transfer of simian immunodeficiency virus (SIV) naïve autologous CD4(+) cells to macaques chronically infected with SIV is sufficient to induce long-term nonprogressor status. Villinger F; Brice GT; Mayne AE; Bostik P; Mori K; June CH; Ansari AA Blood; 2002 Jan; 99(2):590-9. PubMed ID: 11781243 [TBL] [Abstract][Full Text] [Related]
11. Control of SIV rebound through structured treatment interruptions during early infection. Lori F; Lewis MG; Xu J; Varga G; Zinn DE; Crabbs C; Wagner W; Greenhouse J; Silvera P; Yalley-Ogunro J; Tinelli C; Lisziewicz J Science; 2000 Nov; 290(5496):1591-3. PubMed ID: 11090360 [TBL] [Abstract][Full Text] [Related]
12. Short communication: no evidence of occult SHIV infection as demonstrated by CD8+ cell depletion after chemoprophylaxis-induced protection from mucosal infection in rhesus macaques. Kersh EN; Luo W; Adams DR; Mitchell J; Garcia-Lerma JG; Heneine W; Folks TM; Butera S; Otten RA AIDS Res Hum Retroviruses; 2008 Apr; 24(4):543-6. PubMed ID: 18370590 [TBL] [Abstract][Full Text] [Related]
13. Response of simian immunodeficiency virus to the novel nucleoside reverse transcriptase inhibitor 4'-ethynyl-2-fluoro-2'-deoxyadenosine in vitro and in vivo. Murphey-Corb M; Rajakumar P; Michael H; Nyaundi J; Didier PJ; Reeve AB; Mitsuya H; Sarafianos SG; Parniak MA Antimicrob Agents Chemother; 2012 Sep; 56(9):4707-12. PubMed ID: 22713337 [TBL] [Abstract][Full Text] [Related]
14. Prevention of SIV rectal transmission and priming of T cell responses in macaques after local pre-exposure application of tenofovir gel. Cranage M; Sharpe S; Herrera C; Cope A; Dennis M; Berry N; Ham C; Heeney J; Rezk N; Kashuba A; Anton P; McGowan I; Shattock R PLoS Med; 2008 Aug; 5(8):e157; discussion e157. PubMed ID: 18684007 [TBL] [Abstract][Full Text] [Related]
15. Initiation of antiretroviral therapy 48 hours after infection with simian immunodeficiency virus potently suppresses acute-phase viremia and blocks the massive loss of memory CD4+ T cells but fails to prevent disease. Kubo M; Nishimura Y; Shingai M; Lee W; Brenchley J; Lafont B; Buckler-White A; Igarashi T; Martin MA J Virol; 2009 Jul; 83(14):7099-108. PubMed ID: 19420078 [TBL] [Abstract][Full Text] [Related]
16. Passive infusion of immune serum into simian immunodeficiency virus-infected rhesus macaques undergoing a rapid disease course has minimal effect on plasma viremia. Binley JM; Clas B; Gettie A; Vesanen M; Montefiori DC; Sawyer L; Booth J; Lewis M; Marx PA; Bonhoeffer S; Moore JP Virology; 2000 Apr; 270(1):237-49. PubMed ID: 10772996 [TBL] [Abstract][Full Text] [Related]
17. SIV-specific T lymphocyte responses in PBMC and lymphoid tissues of SIV-infected pigtailed macaques during suppressive combination antiretroviral therapy. Carruth LM; Zink MC; Tarwater PM; Miller MD; Li M; Queen LA; Mankowski JL; Shen A; Siliciano RF; Clements JE J Med Primatol; 2005 Jun; 34(3):109-21. PubMed ID: 15860119 [TBL] [Abstract][Full Text] [Related]
18. CD8(+) Lymphocytes Are Required for Maintaining Viral Suppression in SIV-Infected Macaques Treated with Short-Term Antiretroviral Therapy. Cartwright EK; Spicer L; Smith SA; Lee D; Fast R; Paganini S; Lawson BO; Nega M; Easley K; Schmitz JE; Bosinger SE; Paiardini M; Chahroudi A; Vanderford TH; Estes JD; Lifson JD; Derdeyn CA; Silvestri G Immunity; 2016 Sep; 45(3):656-668. PubMed ID: 27653601 [TBL] [Abstract][Full Text] [Related]
19. Differential Impact of In Vivo CD8+ T Lymphocyte Depletion in Controller versus Progressor Simian Immunodeficiency Virus-Infected Macaques. Chowdhury A; Hayes TL; Bosinger SE; Lawson BO; Vanderford T; Schmitz JE; Paiardini M; Betts M; Chahroudi A; Estes JD; Silvestri G J Virol; 2015 Sep; 89(17):8677-86. PubMed ID: 26063417 [TBL] [Abstract][Full Text] [Related]
20. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Schmitz JE; Kuroda MJ; Santra S; Sasseville VG; Simon MA; Lifton MA; Racz P; Tenner-Racz K; Dalesandro M; Scallon BJ; Ghrayeb J; Forman MA; Montefiori DC; Rieber EP; Letvin NL; Reimann KA Science; 1999 Feb; 283(5403):857-60. PubMed ID: 9933172 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]